Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients.
Gisbert JP, Bermejo F, Castro-Fernández M, Pérez-Aisa A, Fernández-Bermejo M, Tomas A, Barrio J, Bory F, Almela P, Sánchez-Pobre P, Cosme A, Ortiz V, Niño P, Khorrami S, Benito LM, Carneros JA, Lamas E, Modolell I, Franco A, Ortuño J, Rodrigo L, García-Durán F, O'Callaghan E, Ponce J, Valer MP, Calvet X; H. pylori Study Group of the Asociación Española de Gastroenterología. Gisbert JP, et al. Among authors: lamas e. Am J Gastroenterol. 2008 Jan;103(1):71-6. doi: 10.1111/j.1572-0241.2007.01500.x. Epub 2007 Aug 31. Am J Gastroenterol. 2008. PMID: 17764498 Clinical Trial.
Third-line rescue therapy with levofloxacin after two H. pylori treatment failures.
Gisbert JP, Castro-Fernández M, Bermejo F, Pérez-Aisa A, Ducons J, Fernández-Bermejo M, Bory F, Cosme A, Benito LM, López-Rivas L, Lamas E, Pabón M, Olivares D; H. pylori Study Group of the Asociación Española de Gastroenterología. Gisbert JP, et al. Among authors: lamas e. Am J Gastroenterol. 2006 Feb;101(2):243-7. doi: 10.1111/j.1572-0241.2006.00457.x. Am J Gastroenterol. 2006. PMID: 16454825 Clinical Trial.
Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients.
Gisbert JP, Pérez-Aisa A, Bermejo F, Castro-Fernández M, Almela P, Barrio J, Cosme A, Modolell I, Bory F, Fernández-Bermejo M, Rodrigo L, Ortuño J, Sánchez-Pobre P, Khorrami S, Franco A, Tomas A, Guerra I, Lamas E, Ponce J, Calvet X; H. pylori Study Group of the Asociación Española de Gastroenterología (Spanish Gastroenterology Association). Gisbert JP, et al. Among authors: lamas e. J Clin Gastroenterol. 2013 Feb;47(2):130-5. doi: 10.1097/MCG.0b013e318254ebdd. J Clin Gastroenterol. 2013. PMID: 22647827
Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures.
Gisbert JP, Castro-Fernandez M, Perez-Aisa A, Cosme A, Molina-Infante J, Rodrigo L, Modolell I, Cabriada JL, Gisbert JL, Lamas E, Marcos E, Calvet X. Gisbert JP, et al. Among authors: lamas e. Aliment Pharmacol Ther. 2012 Apr;35(8):941-7. doi: 10.1111/j.1365-2036.2012.05053.x. Epub 2012 Feb 28. Aliment Pharmacol Ther. 2012. PMID: 22372560 Free article.
Efficacy of triple therapy with a proton pump inhibitor, levofloxacin, and amoxicillin as first-line treatment to eradicate Helicobacter pylori.
Castro-Fernández M, Lamas E, Pérez-Pastor A, Pabón M, Aparcero R, Vargas-Romero J, Larraona JL, Romero-Gómez M. Castro-Fernández M, et al. Among authors: lamas e. Rev Esp Enferm Dig. 2009 Jun;101(6):395-8, 399-402. doi: 10.4321/s1130-01082009000600004. Rev Esp Enferm Dig. 2009. PMID: 19630462 Free article. Clinical Trial. English, Spanish.
Relationship between H. pylori and hepatitis A virus infection.
Castro-Fernández M, Vargas-Romero J, Hoyas E, Lamas E, Millán R, Romero-Gómez M. Castro-Fernández M, et al. Among authors: lamas e. Rev Esp Enferm Dig. 2012 Apr;104(4):220-1. doi: 10.4321/s1130-01082012000400012. Rev Esp Enferm Dig. 2012. PMID: 22537375 Free article. No abstract available.
Trial design of the MOTheR HDx study: a multicenter, open-label, prospective, randomized study to explore the morbidity and mortality in patients dialyzed with the Theranova HDx in comparison with online hemodiafiltration.
de Sequera P, Pérez-García R, Vega A, Martínez-Vaquera S, Acosta JG, Pérez Del Valle K, Fernández-Lucas M, García-Rubiales MA, García-Herrera AL, Coll E, Mérida E, Martínez-Miguel P, Castaño I, Gil-Casares B, Garro J, Maduell F; MOTheR collaborative network. de Sequera P, et al. Clin Kidney J. 2023 May 27;16(11):2254-2261. doi: 10.1093/ckj/sfad128. eCollection 2023 Nov. Clin Kidney J. 2023. PMID: 37915938 Free PMC article.
An Integrated Care Platform System (C3-Cloud) for Care Planning, Decision Support, and Empowerment of Patients With Multimorbidity: Protocol for a Technology Trial.
von Tottleben M, Grinyer K, Arfa A, Traore L, Verdoy D, Lim Choi Keung SN, Larranaga I, Jaulent MC, De Manuel Keenoy E, Lilja M, Beach M, Marguerie C, Yuksel M, Laleci Erturkmen GB, Klein GO, Lindman P, Mar J, Kalra D; C3-Cloud Research Team; Arvanitis TN. von Tottleben M, et al. JMIR Res Protoc. 2022 Jul 13;11(7):e21994. doi: 10.2196/21994. JMIR Res Protoc. 2022. PMID: 35830239 Free PMC article.
112 results